Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04168736 · ClinicalTrials.gov registry record
Family Disclosure in Cascade Testing
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 50
- Enrollment target
NCT04168736: Completed study, sponsored by University of Virginia.
NCT04168736 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04168736 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Prospective cohort study to evaluate the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members. A pre and post test will be administered to consented patients before and after genetic counseling .
Primary Outcome
Evaluate the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members
Interventions
- OTHER Feasibility and Acceptability of Genetic Counseling Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2018-12-30 |
What the finished NCT04168736 record still lists
NCT04168736 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Feasibility and Acceptability of Genetic Counseling Materials is the first listed.
NCT04168736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04168736 about?
NCT04168736 is a clinical study titled "Family Disclosure in Cascade Testing". Prospective cohort study to evaluate the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members. A pre and post test will be administered to consented patients before and after genetic counseling .
What is the current status of trial NCT04168736?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-06-30. Estimated completion is 2018-12-30.
What interventions are being tested in trial NCT04168736?
The interventions under investigation include: Feasibility and Acceptability of Genetic Counseling Materials (OTHER).
Who is sponsoring clinical trial NCT04168736?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI